Clarius Group LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,007	Closed	-$239K	–	514
2022 Q4	$239K	Sell	1,007 -20	-2%	-$4.75K	0.02%	438
2022 Q3	$206K	Buy	+1,027	New	+$206K	0.02%	449